About the Radiopharmaceuticals Session
Radiopharmaceuticals play a pivotal role in cancer research, offering targeted therapy and diagnostic imaging capabilities. These specialized drugs consist of a radioactive component linked to a pharmaceutical compound, allowing precise delivery of radiation to cancerous cells while minimizing damage to healthy tissue. In cancer research, radiopharmaceuticals aid in understanding tumor biology, assessing treatment response, and developing personalized treatment plans. They enable clinicians to visualize tumors with high sensitivity, guiding biopsy procedures and monitoring disease progression. Moreover, radiopharmaceutical therapy delivers therapeutic doses of radiation directly to cancer cells, offering a promising avenue for precision treatment. As research progresses, the development of novel radiopharmaceuticals holds great potential for advancing cancer diagnosis and therapy, improving patient outcomes, and shaping the future of oncology.
Topics Covered in Radiopharmaceuticals
Radioligand Therapy
Alpha & Beta Emitters
Radiolabeling Chemistry
Isotope Production
Diagnostic Tracers
Organ Dosimetry
Related Scientific Sessions at CIOC 2027
Why Attend the Radiopharmaceuticals Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Radiopharmaceuticals work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Radiopharmaceuticals research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Radiopharmaceuticals track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Radiopharmaceuticals Conference 2027 — FAQs
What is the Radiopharmaceuticals track at CIOC 2027?
The Radiopharmaceuticals track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Radiopharmaceuticals. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Radiopharmaceuticals sessions?
Cancer researchers and clinicians, educators and students with an interest in Radiopharmaceuticals are all welcome — whether presenting or attending.
Can I present my research in the Radiopharmaceuticals track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Radiopharmaceuticals sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Radiopharmaceuticals track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.